male genitourinnary

User Generated


Health Medical


Question 1

Discuss the findings of BPH and prostate cancer. How would the presentation differ? What is the significance of the PSA testing in these patients? How would you differentiate between BPH and prostate cancer? What would your treatment plan be for each?

Question 2

Think about your community as a whole. What cultures are represented there? Choose a culture and review the cultural response to male circumcision. Cite references and supporting material.

Question 3

Discuss three differential diagnoses for patients that present with scrotal pain, both acute and chronic causes. What diagnostic tests would be ordered and treatment initiated?

Question 4

Discuss the recommendations for skin examination. What populations are at increased risk of developing skin cancer? What recommendations can we give to our patients (from the pediatric to geriatric patient) regarding sun exposure?

Question 5

A 72-year-old female presents with complaints of a rash near the gluteal fold on the right side. It is a painful vesicular rash, onset approximately 2 days ago, with no fever but occasional burning and sensitivity at the site. She has tried triple antibiotic ointment without relief. She has been widowed for 10 years and has a "steady boyfriend" whom she has dated for 6 months and recently became sexually active with. What other questions would you like to ask your patient? What are your differential diagnoses and final diagnosis? How would you discuss this diagnosis with your older patient?

Question 6

Describe the difference in lesion characteristics between benign and malignant lesions. Discuss three common benign lesions and three precancerous or cancerous lesions.

User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer



Male Genitourinary Discussion
Institutional Affiliation




Question 1
The current findings indicate that prostate cancer is the second most prevalent cancer
affecting men globally. The findings further suggest that the majority of men will develop benign
prostatic hyperplasia (BPH) by the time they reach the age of sixty years. The two prostatic
diseases have a considerable level of morbidity and mortality which will affect a billion men
globally (Remzi & Djavan, 2004). It is imperative to understand that BPH and prostate cancer
have common pathophysiological driving factors. In other words, the presence of benign
prostatic hyperplasia (BPH) is a primary indicator of the risk of specific developing prostate
cancer. The difference in presentation is that benign prostate hyperplasia (BPH) mostly affects
individuals from the age of 51 and the chances increase with age (Remzi & Djavan, 2004).
Prostate-specific antigen (PSA) test is one of the commonly conducted prostate cancer
tests in men. Prostate-specific antigen is a protein that is produced by both normal and malignant
cells of the prostate glands. In this case, the PSA test measures the level of PSA in the blood. The
significance of this test is that men with prostate cancer and BPH often have a high and elevated
level of prostate-specific antigen (PSA) in their blood (Miah & Catto, 2014). This test is,
therefore, a sure indication of the presence of prostate cancer and BPH in men. The main
difference between BPH and protest cancer is that BPH is benign which means that it is not
cancer and it cannot be spread like cancer which can be spread to other parts of ...

Excellent! Definitely coming back for more study materials.


Similar Content

Related Tags